Product Information
METHAZOLAMIDE 25 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.6275 per EA under NDC 62559024001. Its NADAC has been published 618 times since Dec 3, 2014.
FDA first approved this application on Jun 30, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559024001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040001FDA Approved
6/30/1993
TE Code
AB
On Market Since
11/6/2014
Price Statistics
The NADAC for METHAZOLAMIDE 25 MG TABLET has been published 618 times since Dec 3, 2014, and over the history we have for it it has declined 79.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6275 per EA |
|---|---|
| All-time high | $3.1091 (Sep 12, 2018) |
| All-time low | $0.6275 (Sep 23, 2026) |
| 52-week high | $1.0036 |
| 52-week low | $0.6275 |
| Median price | $2.2837 |
| Average price | $2.0888 |
| Largest weekly change | -46.6% (Apr 19, 2023) |
| Weeks tracked | 618 |
| Tracking since | Dec 3, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methazolamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHAZOLAMIDE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHAZOLAMIDE 25 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.6275 per EA (NDC 62559024001), effective Sep 30, 2026.
How has the price of METHAZOLAMIDE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHAZOLAMIDE 25 MG TABLET has declined 79.1%. It has been tracked across 618 weekly CMS publications since Dec 3, 2014.
What are the highest and lowest recorded NADAC prices for METHAZOLAMIDE 25 MG TABLET?
Since Dec 3, 2014, the NADAC for METHAZOLAMIDE 25 MG TABLET has ranged from a low of $0.6275 (Sep 23, 2026) to a high of $3.1091 (Sep 12, 2018), with a median of $2.2837 per EA.
Are there cheaper alternatives to METHAZOLAMIDE 25 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHAZOLAMIDE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHAZOLAMIDE 25 MG TABLET?
METHAZOLAMIDE 25 MG TABLET (NDC 62559024001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.